tirzepatide phase 2 obesity on ingestive behavior in adults with overweight or obesity: a randomized 6-week 1 trial Frontiers | Tirzepatide vs. semaglutide

Its important to note that testing too early may result in a false negative, as the hormone levels may not yet be high enough to be detected

Decreases glucagon levels, reducing excess glucose production by the liver

Once you begin using a vial or pen, storage duration depends on the specific formulation and manufacturer instructions provided with your PlexusDx shipment

Key terminology: Length refers to the needle, not the syringe barrel

Key points: GLP-1 use: More patients are presenting for procedures while taking GLP-1RAs for diabetes or weight loss Main concern: GLP-1RAs can delay gastric emptying, which may increase aspiration risk during sedation Continue therapy: Current guidance supports continuing GLP-1RAs in patients without significant aspiration risk, using shared decision-making Assess risk factors: Recent start or dose escalation, weekly/high-dose therapy, GI symptoms, gastroparesis or other motility disorders Key takeaway: Most interventional pain procedures can be performed safely with local anesthetic alone, making conscious sedation unnecessary in many cases Conclusion: This study highlights the importance of individualized risk assessment and avoiding unnecessary sedation to improve safety in patients taking GLP-1RAs